These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 17997810

  • 1. The biology behind the new therapies for SLE.
    Ermann J, Bermas BL.
    Int J Clin Pract; 2007 Dec; 61(12):2113-9. PubMed ID: 17997810
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 3. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
    Dall'era M, Chakravarty EF.
    Curr Rheumatol Rep; 2011 Aug 21; 13(4):308-16. PubMed ID: 21584692
    [Abstract] [Full Text] [Related]

  • 4. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH, Chan TM.
    Int J Mol Sci; 2019 Dec 10; 20(24):. PubMed ID: 31835612
    [Abstract] [Full Text] [Related]

  • 5. Exploring new territory: the move towards individualised treatment.
    Haubitz M.
    Lupus; 2007 Dec 10; 16(3):227-31. PubMed ID: 17432112
    [Abstract] [Full Text] [Related]

  • 6. Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy.
    Pego-Reigosa JM, Isenberg DA.
    Expert Opin Investig Drugs; 2008 Jan 10; 17(1):31-41. PubMed ID: 18095917
    [Abstract] [Full Text] [Related]

  • 7. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
    Yildirim-Toruner C, Diamond B.
    J Allergy Clin Immunol; 2011 Feb 10; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
    [Abstract] [Full Text] [Related]

  • 8. [Recent investigations on the basis of pathogenesis of SLE and new therapeutic approaches].
    Watanabe N, Takabayashi K.
    Nihon Rinsho; 2009 Mar 10; 67(3):500-5. PubMed ID: 19280923
    [Abstract] [Full Text] [Related]

  • 9. B-cell biology and related therapies in systemic lupus erythematosus.
    Ahmed S, Anolik JH.
    Rheum Dis Clin North Am; 2010 Feb 10; 36(1):109-30, viii-ix. PubMed ID: 20202594
    [Abstract] [Full Text] [Related]

  • 10. Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: progress to date.
    Marks SD, Tullus K.
    Paediatr Drugs; 2007 Feb 10; 9(6):371-8. PubMed ID: 18052407
    [Abstract] [Full Text] [Related]

  • 11. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS, Reimold AM.
    Rheumatology (Oxford); 2017 Apr 01; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [Abstract] [Full Text] [Related]

  • 12. Exploring new territory: considering the future.
    Schneider M.
    Lupus; 2007 Apr 01; 16(3):221-6. PubMed ID: 17432111
    [Abstract] [Full Text] [Related]

  • 13. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
    Tsang HH, Trendell-Smith NJ, Wu AK, Mok MY.
    Lupus; 2010 Mar 01; 19(3):330-3. PubMed ID: 19897521
    [Abstract] [Full Text] [Related]

  • 14. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.
    Autoimmun Rev; 2010 Dec 01; 10(2):108-11. PubMed ID: 20804861
    [Abstract] [Full Text] [Related]

  • 15. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
    Marks SD, Tullus K.
    Acta Paediatr; 2010 Jul 01; 99(7):967-74. PubMed ID: 20222881
    [Abstract] [Full Text] [Related]

  • 16. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E, Isenberg D.
    Best Pract Res Clin Rheumatol; 2009 Aug 01; 23(4):563-74. PubMed ID: 19591785
    [Abstract] [Full Text] [Related]

  • 17. Novel therapies of lupus nephritis.
    Schieppati A, Remuzzi G.
    Curr Opin Nephrol Hypertens; 2008 Mar 01; 17(2):156-61. PubMed ID: 18277148
    [Abstract] [Full Text] [Related]

  • 18. Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future.
    Walsh M, Jayne D.
    Kidney Int; 2007 Sep 01; 72(6):676-82. PubMed ID: 17609693
    [Abstract] [Full Text] [Related]

  • 19. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É.
    Ann Dermatol Venereol; 2011 Dec 01; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [Abstract] [Full Text] [Related]

  • 20. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ, Adams A, Lehman TJ.
    Lupus; 2007 Dec 01; 16(8):677-83. PubMed ID: 17711907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.